Expert Opinion on Drug Metabolism & Toxicology
Expert Opinion on Drug Metabolism & Toxicology
期刊ISSN: 1742-5255
E-ISSN: -
影响因子: 登录后查看数据
自引率: 5.9%
SCI期刊JCR分区
SCI期刊JCR分区等级:2区
按学科分区
BIOCHEMISTRY & MOLECULAR BIOLOGY
Q2
PHARMACOLOGY & PHARMACY
Q2
TOXICOLOGY
Q2
BIOCHEMISTRY & MOLECULAR BIOLOGY
Q3
PHARMACOLOGY & PHARMACY
Q3
TOXICOLOGY
Q3
《新锐期刊分区表》(2026年3月发布)
大类学科
医学
3区
小类学科
生化与分子生物学
3区
药学
3区
毒理学
3区
Top期刊
否
综述期刊
否
最新中科院SCI期刊分区(2025年3月升级版)
大类学科
医学
3区
小类学科
毒理学
2区
生化与分子生物学
3区
药学
3区
Top期刊
否
综述期刊
是
期刊简介
Expert Opinion on Drug Metabolism & Toxicology (ISSN 1742-5255 [print], 1744-7607 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on all aspects of ADME-Tox. Each article is structured to incorporate the author’s own expert opinion on the scope for future development. The Editors welcome: Reviews covering metabolic, pharmacokinetic and toxicological issues relating to specific drugs, drug-drug interactions, drug classes or their use in specific populations; issues relating to enzymes involved in the metabolism, disposition and excretion of drugs; techniques involved in the study of drug metabolism and toxicology; novel technologies for obtaining ADME-Tox data. Drug Evaluations reviewing the clinical, toxicological and pharmacokinetic data on a particular drug. The audience consists of scientists and managers in the pharmaceutical industry, pharmacologists, clinical toxicologists and related professionals.
出版信息
出版商
Taylor and Francis Ltd.
涉及的研究方向
医学-生化与分子生物学
刊期
Bimonthly
年文章数
100
出版国家或地区
ENGLAND
是否OA
否
Cite Score(2025年最新版)
Cite Score SJR SNIP 排名
7.2 0.986 1.078
学科
大类学科:Pharmacology, Toxicology and Pharmaceutics
小类学科:Toxicology
分区
Q1
学科
大类学科:Pharmacology, Toxicology and Pharmaceutics
小类学科:Pharmacology
分区
Q2
SCI期刊投稿推荐
JCR分区相关期刊
中科院分区相关期刊
推荐会议
查看更多>
去登录